TNF-inducible expression of lymphotoxin-β in hepatic cells: An essential role for NF-κB and Ets1 transcription factors

Cytokine

Volumn 60, Issue 2, 2012, Pages 498-504

  Subrata, Lily S ^a   Voon, Dominic C ^a   Yeoh, George C T ^a,b   Ulgiati, Daniela ^a   Quail, Elizabeth A ^a   Abraham, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ets1; Lymphotoxin; Oval cells; TNF; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN BETA; MESSENGER RNA; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LIVER CELL; LIVER OVAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; EARLY GROWTH RESPONSE PROTEIN 1; HEP G2 CELLS; HEPATOCYTES; HUMANS; LYMPHOTOXIN-BETA; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEIN C-ETS-1; SP1 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866746557     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.05.029     Document Type: Article

References (38)

1. Androlewicz M.J., Browning J.L., Ware C.F. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 1992, 267:2542-2547.
2. Browning J.L., Dougas I., Ngamek A., Bourdon P.R., Ehrenfels B.N., Miatkowski K., et al. Characterization of surface lymphotoxin forms - use of specific monoclonal-antibodies and soluble receptors. J Immunol 1995, 154:33-46.
3. Ware C.F., Crowe P.D., Grayson M.H., Androlewicz M.J., Browning J.L. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol 1992, 149:3881-3888.
4. Crowe P.D., VanArsdale T.L., Walter B.N., Ware C.F., Hession C., Ehrenfels B., et al. A lymphotoxin-beta-specific receptor. Science 1994, 264:707-710.
5. Browning J.L., French L.E. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. J Immunol 2002, 168:5079-5087.
6. Force W.R., Walter B.N., Hession C., Tizard R., Kozak C.A., Browning J.L., et al. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J Immunol 1995, 155:5280-5288.
7. Voon D.C., Subrata L.S., Abraham L.J. Regulation of lymphotoxin-beta by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells. J Interferon Cytokine Res 2001, 21:921-930.
8. Voon D.C., Subrata L.S., Karimi M., Ulgiati D., Abraham L.J. TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members. J Immunol 2004, 172:4332-4341.
9. Lowes K.N., Croager E.J., Olynyk J.K., Abraham L.J., Yeoh G.C. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol 2003, 18:4-12.
10. Haybaeck J., Zeller N., Wolf M.J., Weber A., Wagner U., Kurrer M.O., et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009, 16:295-308.
11. Akhurst B., Matthews V., Husk K., Smyth M.J., Abraham L.J., Yeoh G.C. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 2005, 41:327-335.
12. Knight B., Matthews V.B., Akhurst B., Croager E.J., Klinken E., Abraham L.J., et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol 2005, 83:364-374.
13. Knight B., Yeoh G.C. TNF/LTalpha double knockout mice display abnormal inflammatory and regenerative responses to acute and chronic liver injury. Cell Tissue Res 2005, 319:61-70.
14. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L.J., Yu C., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000, 192:1809-1818.
15. Viebahn C.S., Benseler V., Holz L.E., Elsegood C.L., Vo M., Bertolino P., et al. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. J Hepatol 2010, 53:500-507.
16. Subrata L.S., Lowes K.N., Olynyk J.K., Yeoh G.C., Quail E.A., Abraham L.J. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines. Liver Int 2005, 25:633-646.
17. Dumble M.L., Croager E.J., Yeoh G.C., Quail E.A. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 2002, 23:435-445.
18. Croager E.J., Gout A.M., Abraham L.J. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 2000, 156:1723-1731.
19. Lim F., Kraut N., Framptom J., Graf T. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism. EMBO J 1992, 11:643-652.
20. Franchina M., Woo A.J., Dods J., Karimi M., Ho D., Watanabe T., et al. The CD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma. J Pathol 2008, 214:65-74.
21. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25:280-288.
22. Pomerantz J.L., Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002, 10:693-695.
23. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002, 17:525-535.
24. Shih V.F., Tsui R., Caldwell A., Hoffmann A. A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 2011, 21:86-102.
25. Sharrocks A.D., Brown A.L., Ling Y., Yates P.R. The ETS-domain transcription factor family. Int J Biochem Cell Biol 1997, 29:1371-1387.
26. Wasylyk B., Hagman J., Gutierrez-Hartmann A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 1998, 23:213-216.
27. Lulli V., Romania P., Morsilli O., Gabbianelli M., Pagliuca A., Mazzeo S., et al. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ 2006, 13:1064-1074.
28. Bories J.C., Willerford D.M., Grevin D., Davidson L., Camus A., Martin P., et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995, 377:635-638.
29. Barton K., Muthusamy N., Fischer C., Ting C.N., Walunas T.L., Lanier L.L., et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998, 9:555-563.
30. Ito M., Nakayama T., Naito S., Matsuu M., Shichijo K., Sekine I. Expression of Ets-1 transcription factor in relation to angiogenesis in the healing process of gastric ulcer. Biochem Biophys Res Commun 1998, 246:123-127.
31. Pande P., Mathur M., Shukla N.K., Ralhan R. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J Pathol 1999, 189:40-45.
32. Zhan Y., Brown C., Maynard E., Anshelevich A., Ni W., Ho I.C., et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005, 115:2508-2516.
33. Wernert N., Raes M.B., Lassalle P., Dehouck M.P., Gosselin B., Vandenbunder B., et al. C-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992, 140:119-127.
34. Iwasaka C., Tanaka K., Abe M., Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996, 169:522-531.
35. Oda N., Abe M., Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 1999, 178:121-132.
36. Hashiya N., Jo N., Aoki M., Matsumoto K., Nakamura T., Sato Y., et al. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 2004, 109:3035-3041.
37. Russell L., Garrett-Sinha L.A. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 2010, 51:217-226.
38. Knittel T., Kobold D., Dudas J., Saile B., Ramadori G. Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. Am J Pathol 1999, 155:1841-1848.